S. Pauselli

Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes

R. Rabadán, R. Foà, S. Chiaretti, 2016, Oncotarget.

A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.

R. Foà, A. Guarini, M. Napolitano, 2015, Blood transfusion = Trasfusione del sangue.

Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients

R. Foà, A. Vitale, A. Guarini, 2015, Cancer Immunology, Immunotherapy.

Immunogenicity of Allo-Vesicle Carrying ERBB2 Tumor Antigen for Dendritic Cell-Based Anti-Tumor Immunotherapy

L. Frati, P. Benedetti‐Panici, G. Spinelli, 2009, International journal of immunopathology and pharmacology.

An update in neoadjuvant chemotherapy in cervical cancer.

R. Angioli, L. Muzii, F. Bellati, 2007, Gynecologic oncology.

Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression

L. Frati, C. Marchetti, A. Rughetti, 2009, Journal of cellular and molecular medicine.

RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients.

M. Biffoni, J. Burchell, A. Rughetti, 2008, International journal of oncology.

Severe warm autoimmune haemolytic anaemia due to anti-Jk(a) autoantibody associated with Parvovirus B19 infection in a child.

G. Girelli, S. Pauselli, M. Iacobini, 2013, Blood transfusion = Trasfusione del sangue.